peginterferon alfa-2b follow-on biologic (Jiangsu Hengrui Medicine)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepeginterferon alfa-2b follow-on biologic (Jiangsu Hengrui Medicine)
Drug Alias Namepeginterferon alfa-2b
ClassificationBiologics > Biosimilar
Mechanisms of ActionInterferon alpha 2 ligandInterferon receptors modulators
TargetsInterferon alpha-2Interferon receptors
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJiangsu Hengrui Medicine Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A